Literature DB >> 27915050

Hypereosinophilia with asthma and systemic (non-vasculitic) manifestations: Eosinophilic granulomatosis with polyangiitis or hypereosinophilic syndrome?

Guillaume Lefèvre1, Félix Ackermann2, Jean-Emmanuel Kahn3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27915050     DOI： 10.1016/j.autrev.2016.11.001

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN： 1568-9972            Impact factor:   9.754


× No keyword cloud information.
  6 in total

Review 1.  Autoimmunity in 2017.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 2.  Autoimmunity in 2016.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

Review 3.  (A Critical Appraisal of) Classification of Hypereosinophilic Disorders.

Authors:  Jean Emmanuel Kahn; Matthieu Groh; Guillaume Lefèvre
Journal:  Front Med (Lausanne)       Date:  2017-12-05

Review 4.  Targeting the Interleukin-5 Pathway for Treatment of Eosinophilic Conditions Other than Asthma.

Authors:  Florence Roufosse
Journal:  Front Med (Lausanne)       Date:  2018-04-06

5.  Acute exacerbation of idiopathic hypereosinophilic syndrome following asymptomatic coronavirus disease 2019: a case report.

Authors:  Satoshi Suzuki; Keiko Suzuki; Takaya Ichikawa; Kae Takahashi; Masako Minami-Hori; Yoko Tanino
Journal:  J Med Case Rep       Date:  2022-08-31

6.  Renal Involvement as Rare Acute Tubulointerstitial Nephritis in a Patient with Eosinophilic Disorder Treated with Early Add-on Administration of Mepolizumab.

Authors:  Yuto Hayama; Fuminori Tomyo; Masaki Ueno; Shinichiro Asakawa; Shigeyuki Arai; Osamu Yamazaki; Yoshifuru Tamura; Makoto Mochizuki; Ryuji Ohashi; Shigeru Shibata; Yoshihide Fujigaki
Journal:  Intern Med       Date:  2021-06-05       Impact factor: 1.271
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.